Saving the Braille printing press

Article

The Scottish Braille Printing Press, the leading provider of Braille books in the UK, has launched an appeal to raise GBP 2 million (approximately E2.1 million).

The Scottish Braille Printing Press, the leading provider of Braille books in the UK, has launched an appeal to raise £2 million (approximately €2.1 million). The appeal, launched to coincide with the 200th anniversary of Louis Braille's birth, aims to raise the money to rehouse the printing press and provide up-to-date equipment, to protect its long-term future.

Currently, it is estimated that 96% of books are never printed in Braille or other low-vision-friendly formats, such as large type or audio.

This week (January 4–10, 2009) also marks National Braille Week in the UK, a week of awareness- and fund-raising activities centred around Braille. To make a donation, please click here.

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.